Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell Medical College

Angiocrine Bioscience, Inc. announced today that it has licensed the rights to a new technology developed by a team of researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College.

http://ift.tt/1kXQaMI